- Report
- April 2025
- 291 Pages
Global
From €5369EUR$5,600USD£4,486GBP
- Report
- May 2024
- 128 Pages
Global
From €6230EUR$6,499USD£5,206GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Report
- August 2022
- 116 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2022
- 60 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1438EUR$1,500USD£1,202GBP
- Report
- August 2021
- 52 Pages
Global
From €3830EUR$3,995USD£3,200GBP
- Report
- August 2022
Global
From €949EUR$990USD£793GBP
- Report
- January 2022
- 131 Pages
Global
From €3259EUR$3,400USD£2,723GBP
- Report
- May 2022
- 49 Pages
Global
From €1917EUR$2,000USD£1,602GBP
Septic shock is a life-threatening condition caused by an infection that overwhelms the body's immune system. It is a major cause of death in hospitalized patients and is treated with a variety of drugs. Infectious diseases drugs used to treat septic shock include antibiotics, antivirals, antifungals, and immunomodulators. Antibiotics are used to treat bacterial infections, antivirals are used to treat viral infections, antifungals are used to treat fungal infections, and immunomodulators are used to modulate the body's immune response.
The septic shock drug market is highly competitive, with a number of companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Johnson & Johnson. Show Less Read more